Mo1544 IS SMALL INTESTINAL DYSBIOSIS (SIBO) RELATED TO IMPROVEMENT OF EPIGASTRIC PAIN, EARLY SATIETY AND POSTPRANDIAL PAIN IN RESPONSE TO ANTIMICROBIAL THERAPY WITH RIFAXIMIN IN PATIENTS WITH FUNCTIONAL GASTROINTESTINAL DISORDERS?

2020 ◽  
Vol 158 (6) ◽  
pp. S-889
Author(s):  
Ayesha Shah ◽  
Nicholas J. Talley ◽  
Natasha A. Koloski ◽  
Marjorie M. Walker ◽  
Gavin Callaghan ◽  
...  
2019 ◽  
Vol 10 (1) ◽  
Author(s):  
George B. Saffouri ◽  
Robin R. Shields-Cutler ◽  
Jun Chen ◽  
Yi Yang ◽  
Heather R. Lekatz ◽  
...  

Gut ◽  
2020 ◽  
Vol 69 (12) ◽  
pp. 2074-2092
Author(s):  
Jeremy M D Nightingale ◽  
Peter Paine ◽  
John McLaughlin ◽  
Anton Emmanuel ◽  
Joanne E Martin ◽  
...  

Adult patients with severe chronic small intestinal dysmotility are not uncommon and can be difficult to manage. This guideline gives an outline of how to make the diagnosis. It discusses factors which contribute to or cause a picture of severe chronic intestinal dysmotility (eg, obstruction, functional gastrointestinal disorders, drugs, psychosocial issues and malnutrition). It gives management guidelines for patients with an enteric myopathy or neuropathy including the use of enteral and parenteral nutrition.


2020 ◽  
Vol 8 (5) ◽  
pp. 691 ◽  
Author(s):  
Georgios Tziatzios ◽  
Paraskevas Gkolfakis ◽  
Ioannis S. Papanikolaou ◽  
Ruchi Mathur ◽  
Mark Pimentel ◽  
...  

Functional dyspepsia (FD) is one of the most prevalent chronic functional gastrointestinal disorders. Several distinct pathophysiological mechanisms, including gastro duodenal motor disorders, visceral hypersensitivity, brain-gut interactions, duodenal subtle inflammation, and genetic susceptibility, have been implicated in the pathogenesis of the disease, so far. However, emerging evidence suggests that both quantitative and qualitative disturbances of the gastrointestinal microbiota may also be implicated. In this context, several studies have demonstrated differences of the commensal bacterial community between patients with FD and healthy controls, while others have shown that intestinal dysbiosis might associate with disease’s symptoms severity. Elucidating these complex interactions constituting the microbiota and host crosstalk, may eventually lead to the discovery of novel, targeted therapeutic approaches that may be efficacious in treating the multiple aspects of the disorder. In this review, we summarize the data of the latest research with focus on the association between gut microbiota alterations and host regarding the pathogenesis of FD.


Sign in / Sign up

Export Citation Format

Share Document